- Home
- CIX vs INZY Comparison
CIX vs INZY Comparison
Compare CIX & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIX
- INZY
- Stock Information
- Founded
- CIX 1993
- INZY 2015
- Country
- CIX United States
- INZY United States
- Employees
- CIX N/A
- INZY N/A
- Industry
- CIX Industrial Machinery/Components
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- CIX Consumer Discretionary
- INZY Health Care
- Exchange
- CIX Nasdaq
- INZY Nasdaq
- Market Cap
- CIX 301.8M
- INZY 256.3M
- IPO Year
- CIX 1998
- INZY 2020
- Fundamental
- Price
- CIX $25.90
- INZY $4.00
- Analyst Decision
- CIX
- INZY Buy
- Analyst Count
- CIX 0
- INZY 9
- Target Price
- CIX N/A
- INZY $15.22
- AVG Volume (30 Days)
- CIX 5.4K
- INZY 1.1M
- Earning Date
- CIX 08-05-2025
- INZY 08-05-2025
- Dividend Yield
- CIX 4.60%
- INZY N/A
- EPS Growth
- CIX N/A
- INZY N/A
- EPS
- CIX 1.46
- INZY N/A
- Revenue
- CIX $148,242,000.00
- INZY N/A
- Revenue This Year
- CIX N/A
- INZY N/A
- Revenue Next Year
- CIX N/A
- INZY N/A
- P/E Ratio
- CIX $18.22
- INZY N/A
- Revenue Growth
- CIX N/A
- INZY N/A
- 52 Week Low
- CIX $17.89
- INZY $0.72
- 52 Week High
- CIX $36.10
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- CIX 58.91
- INZY 82.68
- Support Level
- CIX $22.81
- INZY $3.94
- Resistance Level
- CIX $28.11
- INZY $3.97
- Average True Range (ATR)
- CIX 0.93
- INZY 0.01
- MACD
- CIX 0.32
- INZY -0.09
- Stochastic Oscillator
- CIX 70.94
- INZY 100.00
About CIX CompX International Inc.
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.